Friedrich Laub joined Armstrong Teasdale as a partner in its intellectual property practice in New York, the firm announced Monday.
Laub develops and implements global IP and patent strategies across the biopharmaceuticals, biotechnology, and molecular- and immuno-diagnostics industries, the firm said. He also advises clients on IP transactional matters, such as collaboration, licensing, and mergers and acquisitions deals.
This story was produced by Bloomberg Law Automation.